{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:31:32Z","timestamp":1770881492382,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Helicobacter pylori<\/jats:italic> has been identified as one of the major causes of chronic gastritis, gastric and duodenal ulcers, and gastric cancer. Lipopolysaccharide (LPS) is a major component of the outer membrane of gram-negative bacteria, and <jats:italic>H<\/jats:italic>. <jats:italic>pylori<\/jats:italic> LPS might play an exclusively important role in activating inflammatory pathways in monocytes and macrophages. To study the role of LPS in the underlying mechanism of inflammatory responses, we established an <jats:italic>in vitro<\/jats:italic> model using the human AGS gastric cancer cell line. We found that LPS mediates inflammation through setting off a cascade of events: activation of the store-operated calcium (SOC) channel, initiation of downstream NF-\u03baB signaling, and phosphorylation of extracellular signal-regulated kinase 1\/2 (ERK1\/2). Phosphorylated ERK1\/2 promotes the nuclear translocation of NF-\u03baB, and eventually elevates the expression level of <jats:italic>COX-2<\/jats:italic>, a major inflammatory gene.<\/jats:p>","DOI":"10.1038\/s41598-017-12648-1","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T06:59:29Z","timestamp":1507100369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Store-operated Ca2+ Entry Facilitates the Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Gastric Cancer Cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Jhen-Hong","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hao","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Mai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"12648_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tibtech.2012.11.004","volume":"31","author":"HM Amaro","year":"2013","unstructured":"Amaro, H. M., Barros, R., Guedes, A. C., Sousa-Pinto, I. & Malcata, F. X. Microalgal compounds modulate carcinogenesis in the gastrointestinal tract. Trends Biotechnol \n                           31, 92\u20138 (2013).","journal-title":"Trends Biotechnol"},{"key":"12648_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1751-2980.2012.00647.x","volume":"14","author":"Y Hu","year":"2013","unstructured":"Hu, Y., Fang, J. Y. & Xiao, S. D. Can the incidence of gastric cancer be reduced in the new century? J Dig Dis \n                           14, 11\u20135 (2013).","journal-title":"J Dig Dis"},{"key":"12648_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.coph.2009.06.020","volume":"9","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal, B. B. & Gehlot, P. Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol \n                           9, 351\u201369 (2009).","journal-title":"Curr Opin Pharmacol"},{"key":"12648_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jcb.24389","volume":"114","author":"A Lamb","year":"2013","unstructured":"Lamb, A. & Chen, L. F. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem \n                           114, 491\u20137 (2013).","journal-title":"J Cell Biochem"},{"key":"12648_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/187152612804142206","volume":"12","author":"C Luigiano","year":"2012","unstructured":"Luigiano, C. et al. Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view. Infect Disord Drug Targets \n                           12, 340\u20135 (2012).","journal-title":"Infect Disord Drug Targets"},{"key":"12648_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11894-012-0296-y","volume":"14","author":"A Bhandari","year":"2012","unstructured":"Bhandari, A. & Crowe, S. E. Helicobacter pylori in gastric malignancies. Curr Gastroenterol Rep \n                           14, 489\u201396 (2012).","journal-title":"Curr Gastroenterol Rep"},{"key":"12648_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters, J. G., van Vliet, A. H. M. & Kuipers, E. J. Pathogenesis of Helicobacter pylori Infection. Clinical Microbiology Reviews \n                           19, 449\u2013490 (2006).","journal-title":"Clinical Microbiology Reviews"},{"issue":"Suppl 1","key":"12648_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1523-5378.2011.00876.x","volume":"16","author":"S Backert","year":"2011","unstructured":"Backert, S. & Clyne, M. Pathogenesis of Helicobacter pylori infection. Helicobacter \n                           16(Suppl 1), 19\u201325 (2011).","journal-title":"Helicobacter"},{"key":"12648_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2249.2011.04447.x","volume":"166","author":"JM Kim","year":"2011","unstructured":"Kim, J. M. et al. Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1. Clin Exp Immunol \n                           166, 34\u201345 (2011).","journal-title":"Clin Exp Immunol"},{"key":"12648_CR10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrgastro.2010.154","volume":"7","author":"Y Yamaoka","year":"2010","unstructured":"Yamaoka, Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol \n                           7, 629\u201341 (2010).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12648_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park, B. S. et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature \n                           458, 1191\u20135 (2009).","journal-title":"Nature"},{"key":"12648_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/mmi.12086","volume":"87","author":"M Mally","year":"2013","unstructured":"Mally, M. et al. Glycoengineering of host mimicking type-2 LacNAc polymers and Lewis X antigens on bacterial cell surfaces. Mol Microbiol \n                           87, 112\u201331 (2013).","journal-title":"Mol Microbiol"},{"key":"12648_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carres.2012.03.013","volume":"356","author":"Y Fujimoto","year":"2012","unstructured":"Fujimoto, Y., Shimoyama, A., Suda, Y. & Fukase, K. Synthesis and immunomodulatory activities of Helicobacter pylori lipophilic terminus of lipopolysaccharide including lipid A. Carbohydr Res \n                           356, 37\u201343 (2012).","journal-title":"Carbohydr Res"},{"key":"12648_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1083-4389.2004.00237.x","volume":"9","author":"SO Hynes","year":"2004","unstructured":"Hynes, S. O. et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter \n                           9, 313\u201323 (2004).","journal-title":"Helicobacter"},{"key":"12648_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/infdis\/170.1.135","volume":"170","author":"H Nielsen","year":"1994","unstructured":"Nielsen, H., Birkholz, S., Andersen, L. P. & Moran, A. P. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis \n                           170, 135\u20139 (1994).","journal-title":"J Infect Dis"},{"key":"12648_CR16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/iai.63.4.1183-1187.1995","volume":"63","author":"GI Perez-Perez","year":"1995","unstructured":"Perez-Perez, G. I., Shepherd, V. L., Morrow, J. D. & Blaser, M. J. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun \n                           63, 1183\u20137 (1995).","journal-title":"Infect Immun"},{"key":"12648_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-5793(92)80909-Z","volume":"307","author":"M Baggiolini","year":"1992","unstructured":"Baggiolini, M. & Clark-Lewis, I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett \n                           307, 97\u2013101 (1992).","journal-title":"FEBS Lett"},{"key":"12648_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/bmj.2.5550.468","volume":"2","author":"PR Emmons","year":"1967","unstructured":"Emmons, P. R., Hampton, J. R., Harrison, M. J., Honour, A. J. & Mitchell, J. R. Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J \n                           2, 468\u201372 (1967).","journal-title":"Br Med J"},{"key":"12648_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/01.RES.32.6.712","volume":"32","author":"AJ Lonigro","year":"1973","unstructured":"Lonigro, A. J., Itskovitz, H. D., Crowshaw, K. & McGiff, J. C. Dependency of renal blood flow on prostaglandin synthesis in the dog. Circ Res \n                           32, 712\u20137 (1973).","journal-title":"Circ Res"},{"key":"12648_CR20","first-page":"G601","volume":"245","author":"TA Miller","year":"1983","unstructured":"Miller, T. A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol \n                           245, G601\u201323 (1983).","journal-title":"Am J Physiol"},{"key":"12648_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons, D. L., Botting, R. M. & Hla, T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev \n                           56, 387\u2013437 (2004).","journal-title":"Pharmacol Rev"},{"key":"12648_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1749-6632.2001.tb02731.x","volume":"952","author":"AJ Dannenberg","year":"2001","unstructured":"Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Lin, D. T. & Subbaramaiah, K. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann N Y Acad Sci \n                           952, 109\u201315 (2001).","journal-title":"Ann N Y Acad Sci"},{"key":"12648_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1054\/plef.2001.0335","volume":"66","author":"AT Koki","year":"2002","unstructured":"Koki, A. T. et al. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot Essent Fatty Acids \n                           66, 13\u20138 (2002).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"12648_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0165-6147(02)00043-3","volume":"24","author":"K Subbaramaiah","year":"2003","unstructured":"Subbaramaiah, K. & Dannenberg, A. J. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci \n                           24, 96\u2013102 (2003).","journal-title":"Trends Pharmacol Sci"},{"key":"12648_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.RES.87.6.504","volume":"87","author":"M Soler","year":"2000","unstructured":"Soler, M., Camacho, M., Escudero, J. R., Iniguez, M. A. & Vila, L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res \n                           87, 504\u20137 (2000).","journal-title":"Circ Res"},{"key":"12648_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang, D. & Dubois, R. N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene \n                           29, 781\u20138 (2010).","journal-title":"Oncogene"},{"issue":"Pt 3","key":"12648_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1042\/bj3020723","volume":"302","author":"SB Appleby","year":"1994","unstructured":"Appleby, S. B., Ristimaki, A., Neilson, K., Narko, K. & Hla, T. Structure of the human cyclo-oxygenase-2 gene. Biochem J \n                           302(Pt 3), 723\u20137 (1994).","journal-title":"Biochem J"},{"key":"12648_CR28","first-page":"160","volume":"39","author":"MJ Zenali","year":"2009","unstructured":"Zenali, M. J., Zhang, P. L., Bendel, A. E. & Brown, R. E. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors. Ann Clin Lab Sci \n                           39, 160\u20136 (2009).","journal-title":"Ann Clin Lab Sci"},{"key":"12648_CR29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bbagen.2011.07.001","volume":"1810","author":"MF Hou","year":"2011","unstructured":"Hou, M. F. et al. Orai1\/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim Biophys Acta \n                           1810, 1278\u201384 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"12648_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/molehr\/gar071","volume":"18","author":"C Gomez-Fernandez","year":"2012","unstructured":"Gomez-Fernandez, C., Lopez-Guerrero, A. M., Pozo-Guisado, E., Alvarez, I. S. & Martin-Romero, F. J. Calcium signaling in mouse oocyte maturation: the roles of STIM1, ORAI1 and SOCE. Mol Hum Reprod \n                           18, 194\u2013203 (2012).","journal-title":"Mol Hum Reprod"},{"key":"12648_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.yjmcc.2010.01.020","volume":"48","author":"M Voelkers","year":"2010","unstructured":"Voelkers, M. et al. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol \n                           48, 1329\u201334 (2010).","journal-title":"J Mol Cell Cardiol"},{"key":"12648_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/386855a0","volume":"386","author":"RE Dolmetsch","year":"1997","unstructured":"Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C. & Healy, J. I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature \n                           386, 855\u20138 (1997).","journal-title":"Nature"},{"key":"12648_CR33","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.M110.155895","volume":"286","author":"L Palkowitsch","year":"2011","unstructured":"Palkowitsch, L. et al. The Ca2+ -dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation. J Biol Chem \n                           286, 7522\u201334 (2011).","journal-title":"J Biol Chem"},{"key":"12648_CR34","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/sj.onc.1201731","volume":"16","author":"L Sun","year":"1998","unstructured":"Sun, L. & Carpenter, G. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene \n                           16, 2095\u2013102 (1998).","journal-title":"Oncogene"},{"key":"12648_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037819","volume":"7","author":"EL Moen","year":"2012","unstructured":"Moen, E. L. et al. Regulation of RKIP function by Helicobacter pylori in gastric cancer. PLoS One \n                           7, e37819 (2012).","journal-title":"PLoS One"},{"key":"12648_CR36","first-page":"437","volume":"61","author":"A Grebowska","year":"2010","unstructured":"Grebowska, A. et al. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J Physiol Pharmacol \n                           61, 437\u201342 (2010).","journal-title":"J Physiol Pharmacol"},{"key":"12648_CR37","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3748\/wjg.v17.i35.3971","volume":"17","author":"SK Chuah","year":"2011","unstructured":"Chuah, S. K., Tsay, F. W., Hsu, P. I. & Wu, D. C. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol \n                           17, 3971\u20135 (2011).","journal-title":"World J Gastroenterol"},{"key":"12648_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/path.1868","volume":"208","author":"RM Peek Jr","year":"2006","unstructured":"Peek, R. M. Jr & Crabtree, J. E. Helicobacter infection and gastric neoplasia. J Pathol \n                           208, 233\u201348 (2006).","journal-title":"J Pathol"},{"key":"12648_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/MOG.0b013e32833f1222","volume":"26","author":"A deFoneska","year":"2010","unstructured":"deFoneska, A. & Kaunitz, J. D. Gastroduodenal mucosal defense. Curr Opin Gastroenterol \n                           26, 604\u201310 (2010).","journal-title":"Curr Opin Gastroenterol"},{"key":"12648_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1753425910367813","volume":"17","author":"PJ Hanson","year":"2011","unstructured":"Hanson, P. J., Moran, A. P. & Butler, K. Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. Innate Immun \n                           17, 269\u201382 (2011).","journal-title":"Innate Immun"},{"key":"12648_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/003655201750074456","volume":"36","author":"PC Konturek","year":"2001","unstructured":"Konturek, P. C. et al. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol \n                           36, 1239\u201347 (2001).","journal-title":"Scand J Gastroenterol"},{"key":"12648_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1349-7006.2011.01847.x","volume":"102","author":"H Oshima","year":"2011","unstructured":"Oshima, H. et al. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis. Cancer Sci \n                           102, 713\u20139 (2011).","journal-title":"Cancer Sci"},{"key":"12648_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00281-012-0353-5","volume":"35","author":"H Oshima","year":"2013","unstructured":"Oshima, H. & Oshima, M. The role of PGE2-associated inflammatory responses in gastric cancer development. Semin Immunopathol \n                           35, 139\u201350 (2013).","journal-title":"Semin Immunopathol"},{"key":"12648_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0952-3278(98)90164-8","volume":"58","author":"AM Franchi","year":"1998","unstructured":"Franchi, A. M. & Di Girolamo, G. de los Santos, A. R., Marti, M. L. & Gimeno, M. A. Effects of lysine clonixinate on cyclooxygenase I and II in rat lung and stomach preparations. Prostaglandins Leukot Essent Fatty Acids \n                           58, 421\u20134 (1998).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"12648_CR45","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1124\/mol.104.010900","volume":"67","author":"LC Chen","year":"2005","unstructured":"Chen, L. C., Chen, B. K. & Chang, W. C. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun. Mol Pharmacol \n                           67, 2057\u201369 (2005).","journal-title":"Mol Pharmacol"},{"key":"12648_CR46","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1074\/jbc.M108075200","volume":"277","author":"Y Zhu","year":"2002","unstructured":"Zhu, Y., Saunders, M. A., Yeh, H., Deng, W. G. & Wu, K. K. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT\/enhancer-binding proteins. J Biol Chem \n                           277, 6923\u20138 (2002).","journal-title":"J Biol Chem"},{"key":"12648_CR47","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1093\/emboj\/cdf478","volume":"21","author":"AG Eliopoulos","year":"2002","unstructured":"Eliopoulos, A. G., Dumitru, C. D., Wang, C. C., Cho, J. & Tsichlis, P. N. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. Embo j \n                           21, 4831\u201340 (2002).","journal-title":"Embo j"},{"key":"12648_CR48","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.1128\/MCB.23.24.9233-9244.2003","volume":"23","author":"M Nie","year":"2003","unstructured":"Nie, M., Pang, L., Inoue, H. & Knox, A. J. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol Cell Biol \n                           23, 9233\u201344 (2003).","journal-title":"Mol Cell Biol"},{"key":"12648_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.toxlet.2011.03.017","volume":"203","author":"YH Chou","year":"2011","unstructured":"Chou, Y. H. et al. Divalent lead cations induce cyclooxygenase-2 gene expression by epidermal growth factor receptor\/nuclear factor-kappa B signaling in A431carcinoma cells. Toxicol Lett \n                           203, 147\u201353 (2011).","journal-title":"Toxicol Lett"},{"key":"12648_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ceca.2011.04.004","volume":"50","author":"WC Huang","year":"2011","unstructured":"Huang, W. C. et al. Histamine regulates cyclooxygenase 2 gene activation through Orai1-mediated NFkappaB activation in lung cancer cells. Cell Calcium \n                           50, 27\u201335 (2011).","journal-title":"Cell Calcium"},{"key":"12648_CR51","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.ajpath.2015.04.020","volume":"185","author":"YS Juan","year":"2015","unstructured":"Juan, Y. S. et al. Translocation of NF-kappaB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder. Am J Pathol \n                           185, 2269\u201385 (2015).","journal-title":"Am J Pathol"},{"key":"12648_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","volume":"8","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski, R. Z. & Baldwin, A. S. Jr. NF-kappaB as a therapeutic target in cancer. Trends Mol Med \n                           8, 385\u20139 (2002).","journal-title":"Trends Mol Med"},{"key":"12648_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell \n                           132, 344\u201362 (2008).","journal-title":"Cell"},{"key":"12648_CR54","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1038\/onc.2014.366","volume":"34","author":"JY Wang","year":"2015","unstructured":"Wang, J. Y. et al. STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene \n                           34, 4358\u201367 (2015).","journal-title":"Oncogene"},{"key":"12648_CR55","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1523\/JNEUROSCI.5054-03.2004","volume":"24","author":"JR Ghilardi","year":"2004","unstructured":"Ghilardi, J. R., Svensson, C. I., Rogers, S. D., Yaksh, T. L. & Mantyh, P. W. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J Neurosci \n                           24, 2727\u201332 (2004).","journal-title":"J Neurosci"},{"key":"12648_CR56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy, D. W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med \n                           5, 698\u2013701 (1999).","journal-title":"Nat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12648-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:42:34Z","timestamp":1671795754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12648-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12648"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12648-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"assertion":[{"value":"5 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12813"}}